Loading...
Strattera
ADHD Treatment • Selective norepinephrine reuptake inhibitor
Half-life
5 hours (extensive metabolizers); 21 hours (poor metabolizers)
Protein Binding
98%
Metabolized By
CYP2D6
External
Drugs.comSelectively inhibits norepinephrine reuptake without significant dopamine effects
Drug Class
ADHD Treatment
Subclass
Selective norepinephrine reuptake inhibitor
Half-life
5 hours (extensive metabolizers); 21 hours (poor metabolizers)
Time for plasma concentration to decrease by 50%
Protein Binding
98%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses